Alpha Crest Capital Management LLC Arvinas, Inc. Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$36.01 - $74.24 $43,680 - $90,053
-1,213 Reduced 13.76%
7,603 $320,000
Q1 2022

May 12, 2022
SELL
$60.27 - $81.57 $714,078 - $966,441
-11,848 Reduced 57.34%
8,816 $593,000
Q4 2021

Feb 09, 2022
BUY
$65.85 - $96.21 $1.36 Million - $1.99 Million
20,664 New
20,664 $1.7 Million
Q4 2020

Feb 12, 2021
SELL
$20.19 - $84.93 $452,296 - $1.9 Million
-22,402 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$22.99 - $36.34 $515,021 - $814,088
22,402 New
22,402 $529,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email